The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Mattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 2×
“It has been also suggested thet also inflammation might play a major role in neurodegeneration in Alzheimer's disease ( Mcgeer and Mcgeer, 1995 ).”
BackgroundThe Time Course of Glutamate in the Synaptic Cleft
Clements, J. D., Lester, R. A. J., Tong, G., Jahr, C. E., & Westbrook, G. L. (1992) · Science · doi:10.1126/science.1359647 · Cited by 1,087
Excitotoxity and the NMDA receptor
Rothman, S. M., & Olney, J. W. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90177-9 · Cited by 1,058
Calcium: still center-stage in hypoxic-ischemic neuronal death
Choi, D. W. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80018-w · Cited by 901
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878
Self-citationExcitatory amino acid receptors and synaptic plasticity
Collingridge, G. L., & Singer, W. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90011-v · Cited by 865
Staging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 2×
“…glutamate dysfunction and Alzheimer’s disease: (12) Some authors observed co-localisation of glutamatergic neurones and pathological alterations (neurofibrillary tangles and senile plaques) in post-mortem analysis of the brains of Alzheimer’s patients (Braak et al., 1993; Francis et al., 1993).”
BackgroundGlobus, M. Y. ‐., Busto, R., Dietrich, W. D., Martinez, E., Valdes, I., & Ginsberg, M. D. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01111.x · Cited by 701
Mortimer, J. A., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Rocca, W. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s28 · Cited by 594 · cited 2×
“(13) Head trauma (associated with glutamatergic dysfunction) has been suggested to be an important risk factor for Alzheimer’s disease by some (Mortimer et al., 1991) but not by”
BackgroundResultExcitotoxicity and the NMDA receptor -- still lethal after eight years
Rothman, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93869-y · Cited by 508
Glutamate in CNS disorders as a target for drug development: an update
Parsons, C. G., Danysz, W., & Quack, G. (1998) · Drug News & Perspectives · doi:10.1358/dnp.1998.11.9.863689 · Cited by 438
Self-citationGreenamyre, J., Young, A., & Penney, J. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-08-02133.1984 · Cited by 350
LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., & Quack, G. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00037-1 · Cited by 322
Self-citationParsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00092-k · Cited by 311
Self-citationAmantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Kornhuber, J., Weller, M., Schoppmeyer, K., & Riederer, P. (1994) · PubMed · Cited by 290
Parsons, C. G., Gruner, R., Rozental, J., Millar, J., & Lodge, D. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90029-3 · Cited by 279
Self-citationSenile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain
Giulian, D., Haverkamp, L. J., Li, J., Karshin, W. L., Yu, J., Tom, D., Li, X., & Kirkpatrick, J. B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00067-i · Cited by 242
Francis, P. T., Sims, N. R., Procter, A. W., & Bowen, D. M. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13381.x · Cited by 231
Harris, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230
Contributory mechanisms in the causation of neurodegenerative disorders
Lees, G. J. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90254-d · Cited by 221
Modulation of learning processes by ionotropic glutamate receptor ligands
Danysz, W., Zajaczkowski, W., & Parsons, C. G. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00007 · Cited by 185
Self-citationIs the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
Palmer, A. M., & Gershon, S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2165009 · Cited by 170
Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ
Goodwin, J. L., Uemura, E., & Cunnick, J. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00646-8 · Cited by 165
Schulz, J. B., Matthews, R. T., Henshaw, D. R., & Beal, M. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00527-7 · Cited by 156
Kornhuber, J., & Quack, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11785-u · Cited by 156
Self-citationLow-frequency activation of the NMDA receptor system can prevent the induction of LTP
Coan, E. J., Irving, A. J., & Collingridge, G. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90038-4 · Cited by 156
Caspase Dependent DNA Fragmentation Might Be Associated with Excitotoxicity in Alzheimer Disease
Masliah, E., Mallory, M. E., Alford, M. F., Tanaka, S., & Hansen, L. A. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199811000-00007 · Cited by 151
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 144
Frankiewicz, T., Potier, B., Bashir, Z. I., Collingridge, G. L., & Parsons, C. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15245.x · Cited by 135
Self-citationParsons, C. G., Danysz, W., Bartmann, A., Spielmanns, P., Frankiewicz, T., Hesselink, M. B., Eilbacher, B., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00161-0 · Cited by 133
Self-citationBrorson, J. R., Bindokas, V. P., Iwama, T., Marcuccilli, C. J., Chisholm, J. C., & Miller, R. J. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260305 · Cited by 129
β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
Wu, J., Anwyl, R., & Rowan, M. J. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00031 · Cited by 128
Ditzler, K. (1991) · PubMed · Cited by 127
Görtelmeyer, R., & Erbler, H. C. (1992) · PubMed · Cited by 121
Parsons, C. G., Panchenko, V. A., Pinchenko, V. O., Tsyndrenko, A. Y., & Krishtal, O. A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01228.x · Cited by 114
Self-citationZajaczkowski, W., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00070-1 · Cited by 112
Self-citationFrankiewicz, T., & Parsons, C. G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00060-x · Cited by 110
Self-citationMisztal, M., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00682-6 · Cited by 103
Self-citationWenk, G. L., Danysz, W., & Mobley, S. L. (1995) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)00028-3 · Cited by 98
Self-citationArias, C., Arrieta, I., & Tapia, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410416 · Cited by 96
Hesselink, M. B., de Boer, B. G., Breimer, D. D., & Danysz, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018856020583 · Cited by 72
Self-citationCowburn, R. F., Wiehager, B., Trief, E., Mo, L., & Sundström, E. (1997) · Neurochemical Research · doi:10.1023/a:1021942109490 · Cited by 69
Antiglutamatergic therapy in Alzheimer's disease - effects of lamotrigine
Tekin, S., Bingöl, C. A., Tanrıdağ, T., & Aktan, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050059 · Cited by 69
Cullen, W. K., Wu, J., Anwyl, R., & Rowan, M. J. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00018 · Cited by 65
Low concentrations of inhibit the induction of long-term potentiation in rat hippocampal slices
Izumi, Y., Clifford, D. B., & Zorumski, C. F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90414-3 · Cited by 58
Modifications of neuronal phosphorylated τ immunoreactivity induced by NMDA toxicity
Couratier, P., Lesort, M. J., Sindou, P., Esclaire, F., Yardin, C., & Hugon, J. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815108 · Cited by 55
The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis
Wenk, G. L., Danysz, W., & Roice, D. (1996) · Neuroreport · doi:10.1097/00001756-199606170-00001 · Cited by 54
Self-citationT�pper, R., Gehrmann, J., Banati, R. B., Schwarz, M., Block, F., Noth, J., & Kreutzberg, G. W. (1994) · Acta Neuropathologica · doi:10.1007/bf00294255 · Cited by 50
Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat
Wenk, G. L., Danysz, W., & Mobley, S. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91590-3 · Cited by 48
Self-citationGlumate Receptor Dysfunction and Alzheimer's Disease
Olney, J. W., Wozniak, D. F., & Farber, N. B. (1998) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-1998-00048 · Cited by 41
Risk factors in Alzheimer's disease: A clinicopathologic study
Mendez, M. F., Underwood, K. L., Zander, B. A., Mastri, A. R., Sung, J. H., & Frey, W. H. (1992) · Neurology · doi:10.1212/wnl.42.4.770 · Cited by 41
Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidance
Misztal, M., & Danysz, W. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00015 · Cited by 36
Self-citationFrankiewicz, T., Pilc, A., & Parsons, C. G. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00168-9 · Cited by 35
Self-citationMaker, H. S., & Lehrer, G. M. (1971) · Springer eBooks · doi:10.1007/978-1-4615-7175-9_10 · Cited by 29
Pizzi, M., Valerio, A., Arrighi, V., Gallì, P., Belloni, M., Ribola, M., Alberici, A., Spano, P., & Memo, M. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01156.x · Cited by 20
Couratier, P., Sindou, P., Tabaraud, F., Diop, A. G., Spencer, P. S., & Hugon, J. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0004 · Cited by 16
NMDA antagonist blockade of AT8 tau immunoreactive changes in neuronal cultures
Couratier, P., Lesort, M. J., Terro, F., Dussartre, C., & Hugon, J. (1996) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1996.tb00585.x · Cited by 9
Winblad (1999) · doi:10.1002/(sici)1099-1166(199902)14:2
Klegeris (1997) · doi:10.1002/(sici)1097-4547(19970715)49:2
Cited by
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Self-citationRole of Glutamate and NMDA Receptors in Alzheimer’s Disease
Wang, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160763 · Cited by 1,009
Parsons, C. G., Stöffler, A., & Danysz, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.013 · Cited by 707
Self-citation
Metadata
- Authors
- Danysz, W., Parsons, C. G., MÖbius, H.-J., StÖffler, A., & Quack, G.
- Venue
- Neurotoxicity Research
- Published
- 2000-06
- Volume
- 2
- Issue
- 2-3
- Pages
- 85-97
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W1993788242
- Cited by
- 263
- References
- 63
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.